CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Shawn O’Neil of ViaLase discusses the company’s noninvasive OCT-driven femtosecond laser for glaucoma treatment.
In a case series of 18 eyes that underwent a procedure using ViaLase’s femtosecond laser, 100% of patients experienced a greater than 20% IOP reduction at 24 months, with a 31% mean IOP reduction rate among the total cohort.